CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Revenue	$ 466.6	$ 435.6	$ 1,342.0	$ 1,235.4
Cost of revenue	244.0	236.7	714.8	675.6
Gross profit	222.6	198.9	627.2	559.8
Operating expenses:
Selling, general and administrative	106.5	102.7	327.4	303.3
Research and development	41.8	40.6	128.6	118.5
Other charges, net	5.2	4.3	15.2	13.8
Total operating expenses	153.5	147.6	471.2	435.6
Operating income	69.1	51.3	156.0	124.2
Interest and other income (expense), net	(3.7)	(3.9)	(11.5)	(15.0)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	65.4	47.4	144.5	109.2
Income tax provision	21.2	9.8	41.4	25.9
Consolidated net income	44.2	37.6	103.1	83.3
Net income attributable to noncontrolling interest in consolidated subsidiaries	0.8	0.6	1.5	1.3
Net income attributable to Bruker Corporation	$ 43.4	$ 37.0	$ 101.6	$ 82.0
Net income per common share attributable to Bruker Corporation shareholders:
Basic (in dollars per share)	$ 0.28	$ 0.23	$ 0.65	$ 0.52
Diluted (in dollars per share)	$ 0.28	$ 0.23	$ 0.65	$ 0.51
Weighted average common shares outstanding:
Basic (in shares)	156.4	157.5	156.1	158.9
Diluted (in shares)	157.4	158.7	157.2	159.9
Comprehensive income	$ 41.9	$ 61.2	$ 88.3	$ 170.3
Less: Comprehensive income attributable to noncontrolling interests	0.5	0.7	0.9	1.9
Comprehensive income attributable to Bruker Corporation	$ 41.4	$ 60.5	$ 87.4	$ 168.4
Dividend declared per common share (in dollars per share)	$ 0.04	$ 0.04	$ 0.12	$ 0.12
Product
Revenue	$ 385.5	$ 364.4	$ 1,105.8	$ 1,029.2
Cost of revenue	197.3	195.6	571.6	559.8
Service
Revenue	79.6	70.0	230.8	200.4
Cost of revenue	46.6	40.5	142.2	114.9
Other
Revenue	1.5	1.2	5.4	5.8
Cost of revenue	$ 0.1	$ 0.6	$ 1.0	$ 0.9